退行性二尖瓣病变合并二尖瓣环钙化的瓣膜修复结局
该回顾性研究纳入2002至2015年627例因退行性二尖瓣病变手术患者,其中75例(12%)合并二尖瓣环钙化。合并钙化者早期修复失败率更高(11% vs 3%,p=0.006),但早期死亡率无差异;未使用成形环与修复失败相关,行环部去钙化及成形环植入者修复耐久性与无钙化者相当。
要点
- 合并二尖瓣环钙化者早期修复失败率显著高于无钙化者(11% vs 3%)。
- 修复失败与未使用成形环相关,环部去钙化加成形环植入可获得与无钙化者相当的耐久性。
- 合并钙化者早期死亡率与无钙化者无显著差异(4% vs 2%,p=0.20)。
核心结论
- 退行性二尖瓣病变合并二尖瓣环钙化行瓣膜手术是安全的,但修复失败率更高。
- 最佳策略包括环部去钙化(当钙化妨碍成形环植入时)及成形环植入,可获与无钙化者相近的结果。
- 未处理瓣环时修复效果受损,此类患者未来需探索替代修复技术。
研究设计与样本
- 2002年1月至2015年12月单中心回顾性研究,627例因退行性病变行二尖瓣手术患者。
- 75例(12%)合并二尖瓣环钙化,其中73例(97%)行瓣膜修复(6例未植入成形环),2例(3%)修复失败后行瓣膜置换。
主要发现
- 二尖瓣环钙化与患者年龄、女性性别及退行性病变亚型相关。
- 早期死亡合并钙化者3/75(4%) vs 无钙化者10/552(2%),p=0.20。
- 合并钙化者早期修复失败8/75(11%) vs 无钙化者17/552(3%),p=0.006。
- 随访期总生存率及免于晚期再干预率无差异,但术后8年免于复发性二尖瓣反流在合并钙化者更差。
- 合并钙化者修复失败与未使用成形环相关;行环部去钙化及成形环植入者修复耐久性与无钙化者相当。
临床怎么用
- 对退行性二尖瓣病变合并瓣环钙化者,应行环部去钙化以利成形环植入并植入成形环。
- 避免在未处理瓣环的情况下行修复,否则修复失败风险增加。
局限性
- 原文未报告局限性相关内容。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The risk factors for the development of mitral annular calcification (MAC) in degenerative mitral valve disease and the effect it may have on patient-and valve-related outcomes require further evaluation. METHODS: Between January 2002 and December 2015, 627 patients underwent mitral valve operations for degenerative disease. MAC was seen in 75 patients (12%); 73 (97%) underwent valve repair (6 without annuloplasty ring implantation) and 2 (3%) underwent valve replacement after an unsuccessful repair attempt. RESULTS: MAC was linked to patient age, female sex, and degenerative disease subtype. Early mortality was comparable between patients with and without MAC (3 of 75 [4%] vs 10 of 552 [2%], p = 0.20]. In patients with MAC, one-third of the deaths were directly related to annular decalcification and reconstruction. Early repair failure was more common in patients with MAC (8 of 75 [11%] vs 17 of 552 [3%], p = 0.006). During follow-up, no differences in overall survival or freedom from late reintervention were observed. However, at 8 years after the operation, freedom from recurrent mitral regurgitation was worse in patients with MAC. In these patients, repair failure was linked to nonuse of ring annuloplasty. For patients with MAC in whom annular decalcification and annuloplasty were performed, repair durability was comparable to patients without MAC. CONCLUSIONS: Mitral valve surgery in degenerative disease accompanied by MAC is safe. Optimal surgical strategy includes annular decalcification (when this would prevent implantation of an annuloplasty ring) and ring annuloplasty and will lead to results similar to patients without MAC. However, repair performance is hampered when the annulus is not addressed. For these patients, alternative repair techniques should be explored in the future.
引用
- Tomšič A, Hiemstra YL, van Brakel TJ, et al. Outcomes of Valve Repair for Degenerative Disease in Patients With Mitral Annular Calcification. Ann Thorac Surg. 2018. PMID: 30296421. doi:10.1016/j.athoracsur.2018.08.017
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。